NIGHT FILE
Sermorelin and sleep: slow-wave rest and the nocturnal growth-hormone pulse in the research literature
GHRH(1-29) sits at the same junction where the body's biggest growth-hormone pulse and its deepest sleep overlap. Here is what the controlled studies measured — and why timing is the whole story.
The short version
Your body fires its largest growth-hormone burst at night, during the deepest stage of sleep (slow-wave sleep — the long, slow brain waves of dreamless deep rest). Sermorelin and sleep are linked because sermorelin copies GHRH (the brain's "release growth hormone" signal), the same signal that helps drive both that nocturnal pulse and the deep sleep around it. In studies, GHRH given to healthy men deepened slow-wave sleep, but the effect flipped depending on the time of day it was given — and it faded in older people. That is why night dosing keeps coming up. None of this is a personal instruction; it is what study volunteers showed.
Why sleep and growth hormone are the same story
Most of a day's growth-hormone output is released in pulses, and the largest of those pulses rides on slow-wave sleep — the deep, restorative stage early in the night. GHRH is on both sides of that coincidence: it drives the nocturnal GH pulse, and it influences slow-wave sleep itself.
The cleanest proof that the receptor matters comes from blocking it. When investigators gave healthy people a GHRH-receptor antagonist, nocturnal growth-hormone secretion was suppressed while slow-wave sleep was not abolished — dissociating the two and showing that GHRH-receptor signaling specifically drives the nocturnal GH release [8]. The hormone pulse and the sleep stage travel together, but they are separable, and the receptor is what carries the GH side.
A review of age-related changes in the somatotropic hormones tied this triad — the GH/IGF-1 axis, sleep, and cognition — into one declining system, which is why aging research keeps returning to GHRH at the intersection of all three [9].
What the controlled sleep studies measured
GHRH deepened slow-wave sleep in healthy men. Repeated nocturnal GHRH boluses had sleep-promoting effects in normal men, supporting a physiologic role for GHRH in slow-wave sleep [10]. This is a foundational finding behind the night-dosing logic: the same signal sermorelin imitates can deepen deep sleep in study conditions.
The effect depends on the clock. Changes in sleep-endocrine activity after GHRH depend on the time of administration — give it at one point in the circadian cycle and the sleep-endocrine response differs from another [11]. The sleep benefit is not a fixed property of the molecule; it is time-gated. This is the single most important nuance in the sermorelin-and-sleep conversation, and the reason "when" is asked as often as "whether."
The response shrinks with age. GHRH's ability to modulate sleep-endocrine activity is reduced in the elderly, paralleling the age-related decline of the whole GHRH/GH axis [12]. The population most interested in GH-axis support is also the population in which GHRH's sleep-endocrine effect is most blunted — a tension the honest record keeps visible.
Taken together: GHRH can deepen slow-wave sleep, the effect is circadian-dependent, and it weakens with age. These are measurements in study volunteers, not outcomes promised to an individual.
Does sermorelin actually help with sleep, or is it waking me up instead?
In controlled studies, GHRH promoted slow-wave sleep in healthy men [10], and the sleep-endocrine effect depends on the time of administration [11] — so timing, not the molecule alone, shapes the result. These are research findings in study settings, not a personal-use guarantee, and reports in research-user communities vary; the literature describes a circadian-gated effect, not a uniform sedative one.
Why is it recommended to inject sermorelin at night?
Endogenous growth hormone is released in pulses, most prominently during slow-wave sleep, and GHRH's sleep-endocrine effects are time-of-administration dependent [11]. Bedtime dosing was the protocol used in pediatric and aging trials — for example, 30 mcg/kg/day at bedtime in the pediatric efficacy study [2]. This describes the studied protocol; it is not a personal dosing instruction.
When is the best time to take sermorelin?
Bedtime administration was used in the pediatric efficacy trial and in aging research, aligning dosing with the body's natural nocturnal GH pulse, and GHRH's sleep-endocrine effect is circadian-dependent [11][2]. That describes study timing rather than a use instruction; the corpus reports what was administered when, not a schedule a reader should follow.